GRI Bio Stock (NASDAQ: GRI) stock price, news, charts, stock research, profile.
Open | $0.44 |
Close | $0.42 |
Volume / Avg. | 285.84K / 600.10K |
Day Range | $0.40 - $0.44 |
52 Wk Range | 0.40 - 161.98 |
Market Cap | $1.26M |
P/E Ratio | 0.01 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 15.01% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GRI Bio (NASDAQ:GRI) through any online brokerage.
Other companies in GRI Bio’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
There is no analysis for GRI Bio to provide a consensus price target.
The stock price for GRI Bio (NASDAQ: GRI) is $0.4301 last updated September 23, 2024 at 6:03 PM EDT.
A quarterly cash dividend of 0.51 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2019 to stockholders of record on December 19, 2019.
GRI Bio’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for GRI Bio.
GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.